Antioxidant Formulation for Reversing Liver Fibrosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for chronic liver diseases such as cirrhosis and hepatitis C virus infection lack effective methods to inhibit fibrosis progression and reverse existing fibrosis, often resulting in severe complications like hepatic encephalopathy and liver cancer, with conventional therapies having significant side effects and limited efficacy.
Innovation Solution
A formulation comprising antioxidants like Salvia miltiorrhiza, Schisandra chinensis, oleanolic acid, Ganoderma lucidum, silymarin, and α-lipoic acid, combined with HCV or NASH active constituents like baicalin/baicalein and berberine, administered orally or parenterally to retard and potentially reverse liver fibrosis and cirrhosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional therapies are used for chronic liver disease, then treatment is provided, but side effects are significant and efficacy is limited
Solution Approach 1:
The patent uses a composite antioxidant formulation containing multiple antioxidants (vitamin C, vitamin E, beta-carotene, selenium, zinc) working synergistically to treat liver disease, replacing single-agent conventional therapies with a multi-component composition that enhances efficacy while reducing side effects
Solution Approach 2:
The patent modifies treatment parameters by using specific dosage ranges and administration protocols for the antioxidant combination, optimizing therapeutic effect while minimizing hepatotoxicity associated with conventional treatments
2Reliability
If fibrosis progression is not inhibited, then liver function deteriorates, but effective inhibition methods are lacking
Solution Approach 1:
The antioxidant formulation is administered to prevent oxidative damage before it causes irreversible fibrosis, counteracting the pathological process at an early stage to maintain liver function and prevent progression to cirrhosis
3Reliability
If existing fibrosis is not reversed, then complications occur, but reversal methods are limited
Solution Approach 1:
The patent converts the harmful effect of accumulated oxidative damage into a beneficial therapeutic opportunity by using high-dose antioxidants to reverse fibrosis and prevent complications, transforming a pathological state into a treatable condition
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation effectively inhibits fibrosis progression and may reverse existing fibrosis in chronic liver diseases, reducing the risk of complications while minimizing side effects, and is suitable for both HCV and NASH-induced conditions.
Implementation Method 1
The formulations and methods provide an improved capability to retard a fibrosis and/or cirrhosis... comprising an antioxidant... to slow the progression of, reverse or resolve, treat or prevent chronic liver disease
Data Source
AI summary
An anti-inflammatory and anti-fibrotic antioxidant formulation for treatment of hepatic oxidative stress and cirrhosis is disclosed. The antioxidant formulation can further include at least one of a hepatitis C virus-specific or a non-alcoholic steatohepatitis-specific formulation comprising one or more compounds to retard the progression of liver fibrosis and possibly reverse an established fibrosis. Methods of treatment or therapies for treating chronic liver disease and chronic hepatitis are also provided.